LINE

    Text:AAAPrint
    Society

    Aussie vitamin maker plans expansion into China's herbal medicine market

    1
    2016-05-06 13:51Xinhua Editor: Mo Hong'e

    Australian pharmaceutical company Blackmores will attempt to tap into the burgeoning herbal medicine market in China and throughout Asia via its new Australian-based business.

    The vitamin maker on Friday announced it had acquired leading local Chinese medicine manufacturer and distributor Global Therapeutics, a group that currently commands an estimated 80 percent share of the Chinese herbal remedy market in Australia, for 17 million U.S. dollars.

    Global Therapeutics, based out of the coastal city of Byron Bay, has two main brands Fusion and Oriental Botanicals which are currently only sold in Australia.

    But with the Chinese natural-remedy market said to be worth 125 million U.S. dollars worldwide per annum, Blackmores' chief executive Christine Holgate said the group would look to push into the world's most populous country, China.

    "It's not going to happen overnight but there is a fantastic opportunity," Holgate told Fairfax Media on Friday.

    "It will enable us to better understand the Chinese consumer and get closer to them."

    Last year, the Federal government removed its pre-existing 4-6 percent tariff on Australian pharmaceutical exports, such as vitamins, to China by signing the Chinese-Australian Free Trade Agreement (ChAFTA).

    By 2019, 95 percent of Australian healthcare exports must be tariff-free to satisfy the terms of the historic document.

    In the past 12 months alone, Global Therapeutics' domestic sales have increased by 24 percent, Holgate said.

    Holgate said Australia currently has more than 4,700 registered Chinese medicine practitioners, and the market showed no signs of slowing down.

    Despite Blackmores' success on the Australian Stock Exchange, largely stemming from the massive demand in China for its "clean and green" vitamin products, Holman said there was still room for improving its range.

    Holgate said Blackmores' upper management had identified natural remedies as one of the company's biggest weaknesses.

    "It's the natural medicine part we've not been strong in," she said on Friday.

    Asian buyers now make up around 50 percent of Blackmores' total sales, a figure that could likely expand through exporting Fusion and Oriental Botanicals.

    Blackmores has no plans to rebrand the Fusion and Oriental Botanicals for the Chinese market, Holgate said.

     

      

    Related news

    MorePhoto

    Most popular in 24h

    MoreTop news

    MoreVideo

    News
    Politics
    Business
    Society
    Culture
    Military
    Sci-tech
    Entertainment
    Sports
    Odd
    Features
    Biz
    Economy
    Travel
    Travel News
    Travel Types
    Events
    Food
    Hotel
    Bar & Club
    Architecture
    Gallery
    Photo
    CNS Photo
    Video
    Video
    Learning Chinese
    Learn About China
    Social Chinese
    Business Chinese
    Buzz Words
    Bilingual
    Resources
    ECNS Wire
    Special Coverage
    Infographics
    Voices
    LINE
    Back to top Links | About Us | Jobs | Contact Us | Privacy Policy
    Copyright ©1999-2018 Chinanews.com. All rights reserved.
    Reproduction in whole or in part without permission is prohibited.
    主站蜘蛛池模板: 呼伦贝尔市| 开鲁县| 黔南| 寿宁县| 满城县| 谷城县| 清流县| 清远市| 临高县| 盱眙县| 肥西县| 南靖县| 钟山县| 应城市| 天等县| 乃东县| 桂平市| 鹿邑县| 合肥市| 柞水县| 永川市| 郁南县| 固阳县| 开阳县| 山西省| 资中县| 邮箱| 深圳市| 九龙城区| 铜鼓县| 罗甸县| 交口县| 井冈山市| 镇远县| 曲麻莱县| 鲜城| 台前县| 山东省| 万源市| 营山县| 嘉峪关市|